Your browser doesn't support javascript.
loading
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries.
Pombo-Suarez, Manuel; Sanchez-Piedra, Carlos; Gómez-Reino, Juan; Lauper, Kim; Mongin, Denis; Iannone, Florenzo; Pavelka, Karel; Nordström, Dan C; Inanc, Nevsun; Codreanu, Catalin; Hyrich, Kimme L; Choquette, Denis; Strangfeld, Anja; Leeb, Burkhard F; Rotar, Ziga; Rodrigues, Ana; Kristianslund, Eirik Klami; Kvien, Tore K; Elkayam, Ori; Lukina, Galina; Bergstra, Sytske Anne; Finckh, Axel; Courvoisier, Delphine Sophie.
Afiliación
  • Pombo-Suarez M; Rheumatology Department, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain mpombosuarez@gmail.com.
  • Sanchez-Piedra C; Health Technology Assessment Agency, Instituto de Salud Carlos III, Madrid, Spain.
  • Gómez-Reino J; Fundacion IDIS, Hospital Clinico Universitario, Santiago de Compostela, Spain.
  • Lauper K; Division of Rheumatology, Department of Internal Medicine and Department of Medicine, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.
  • Mongin D; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Iannone F; Division of Rheumatology, Department of Internal Medicine and Department of Medicine, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.
  • Pavelka K; GISEA, DETO Rheumatology Unit, University of Bari, Bari, Italy.
  • Nordström DC; Department of Rheumatology, Charles University, Praha, Czech Republic.
  • Inanc N; ROB-FIN, Departments of Medicine and Rheumatology, Helsinki University Hospital and Helsinki University, Helsinki, Finland.
  • Codreanu C; Division of Rheumatology, Marmara University School of Medicine, Istanbul, Turkey.
  • Hyrich KL; Rheumatology, Center of Rheumatic Diseases, University of Medicine and Pharmacy, Bucharest, Romania.
  • Choquette D; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Strangfeld A; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Leeb BF; Institut de Recherche en Rhumatologie de Montréal, University of Montreal, Montreal, Quebec, Canada.
  • Rotar Z; Epidemiology Unit, German Rheumatism Research Center (DRFZ), Berlin, Germany.
  • Rodrigues A; Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany.
  • Kristianslund EK; BioReg, Vienna, Austria.
  • Kvien TK; Private Office, Hollabrunn, Austria.
  • Elkayam O; Department of Rheumatology, University Medical Centre, Ljubljana, Slovenia.
  • Lukina G; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Bergstra SA; Unidade de Reumatologia, Hospital Lusiadas, Lisbon, Portugal.
  • Finckh A; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
  • Courvoisier DS; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
Ann Rheum Dis ; 82(2): 175-181, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36100351

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Antirreumáticos / Inhibidores de las Cinasas Janus Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2023 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Antirreumáticos / Inhibidores de las Cinasas Janus Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2023 Tipo del documento: Article País de afiliación: España